Oak Ridge Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-40,694
| Closed | -$1.89M | – | 164 |
|
|
2018
Q1 | $1.89M | Sell |
40,694
-28,772
| -41% | -$1.34M | 0.11% | 132 |
|
|
2017
Q4 | $2.61M | Sell |
69,466
-16,944
| -20% | -$635K | 0.12% | 126 |
|
|
2017
Q3 | $4.6M | Sell |
86,410
-49,770
| -37% | -$2.65M | 0.19% | 109 |
|
|
2017
Q2 | $7.76M | Sell |
136,180
-7,811
| -5% | -$445K | 0.25% | 98 |
|
|
2017
Q1 | $7.74M | Sell |
143,991
-39,036
| -21% | -$2.1M | 0.26% | 91 |
|
|
2016
Q4 | $10.4M | Sell |
183,027
-28,131
| -13% | -$1.6M | 0.34% | 73 |
|
|
2016
Q3 | $13.1M | Sell |
211,158
-20,770
| -9% | -$1.29M | 0.34% | 78 |
|
|
2016
Q2 | $13.1M | Sell |
231,928
-4,273
| -2% | -$242K | 0.34% | 77 |
|
|
2016
Q1 | $15.1M | Buy |
236,201
+69,034
| +41% | +$4.42M | 0.38% | 77 |
|
|
2015
Q4 | $23.5M | Buy |
+167,167
| New | +$23.5M | 0.56% | 57 |
|